Concepedia

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Sherif Gonem, Rachid Berair, Amisha Singapuri, Ruth Hartley, Marie Laurencin, Gerald Bacher, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord,

The Lancet Respiratory Medicine · 2016 · 248 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Development and validation of a questionnaire to measure asthma control

Elizabeth F. Juniper, Paul M. O’Byrne, Gordon Guyatt et al. · European Respiratory Journal · 1999 · 2.5K citations · Full text

, , +8

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

, , +14

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon et al. · New England Journal of Medicine · 2009 · 1.9K citations · Full text

, , +11

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

Ruth H. Green, Christopher E. Brightling, Susan McKenna et al. · The Lancet · 2002 · 1.8K citations

, , +14

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

, , +12